☰

Leonel Rojo, Ph.D. - Publications

Affiliations: 
Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Neuropharmacology
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Andrade V, Wong-Guerra M, Cortés N, Pastor G, González A, Calfío C, Guzmán-Martínez L, Navarrete LP, Ramos-Escobar N, Morales I, Santander R, Andrades-Lagos J, Bacho M, Rojo LE, Maccioni RB. Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland). 16. PMID 37513872 DOI: 10.3390/ph16070960  0.737
2023 Wong-Guerra M, Calfio C, Maccioni RB, Rojo LE. Revisiting the neuroinflammation hypothesis in Alzheimer's disease: a focus on the druggability of current targets. Frontiers in Pharmacology. 14: 1161850. PMID 37361208 DOI: 10.3389/fphar.2023.1161850  0.685
2020 Calfio C, Gonzalez A, Singh SK, Rojo LE, Maccioni RB. The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32651325 DOI: 10.3233/JAD-200443  0.636
2020 Andrade V, Cortés N, Pastor G, Gonzalez A, Ramos-Escobar N, Pastene E, Rojo LE, Maccioni RB. N-Acetyl Cysteine and Catechin-Derived Polyphenols: A Path Toward Multi-Target Compounds Against Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32390631 DOI: 10.3233/JAD-200067  0.661
2013 Kuljiš RO, Colom LV, Rojo LE. Biological basis for cerebral dysfunction in schizophrenia in contrast with Alzheimer's disease. Frontiers in Psychiatry. 4: 119. PMID 24550846 DOI: 10.3389/fpsyt.2013.00119  0.646
2011 Rojo LE, Gaspar PA, Maccioni RB. Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates? Current Alzheimer Research. 8: 652-8. PMID 21605040 DOI: 10.2174/156720511796717203  0.655
2010 Rojo LE, Alzate-Morales J, Saavedra IN, Davies P, Maccioni RB. Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 573-89. PMID 20110603 DOI: 10.3233/JAD-2010-1262  0.627
2009 Maccioni RB, Rojo LE, Fernández JA, Kuljis RO. The role of neuroimmunomodulation in Alzheimer's disease. Annals of the New York Academy of Sciences. 1153: 240-6. PMID 19236346 DOI: 10.1111/j.1749-6632.2008.03972.x  0.736
2009 Maccioni RB, Farias GA, Rojo LE, Sekler MA, Kuljis RO. What have we learned from the tau hypothesis? Current Hypotheses and Research Milestones in Alzheimer's Disease. 49-62. DOI: 10.1007/978-0-387-87995-6_5  0.651
2009 Rojo LE, Fernández J, Jiménez J, Maccioni AA, Sekler A, Kuljis RO, Maccioni RB. Central nervous system inflammation and cholesterol metabolism alterations in the pathogenesis of Alzheimer's disease and their diagnostic and therapeutic implications Current Hypotheses and Research Milestones in Alzheimer's Disease. 125-137. DOI: 10.1007/978-0-387-87995-6_11  0.732
2008 Sekler A, Jiménez JM, Rojo L, Pastene E, Fuentes P, Slachevsky A, Maccioni RB. Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism. Neuropsychiatric Disease and Treatment. 4: 715-22. PMID 19043515 DOI: 10.2147/Ndt.S3268  0.644
2008 Neumann KF, Rojo L, Navarrete LP, Farías G, Reyes P, Maccioni RB. Insulin resistance and Alzheimer's disease: molecular links & clinical implications. Current Alzheimer Research. 5: 438-47. PMID 18855585 DOI: 10.2174/156720508785908919  0.609
2008 Fernández JA, Rojo L, Kuljis RO, Maccioni RB. The damage signals hypothesis of Alzheimer's disease pathogenesis. Journal of Alzheimer's Disease : Jad. 14: 329-33. PMID 18599959 DOI: 10.3233/Jad-2008-14307  0.74
2008 Lavados M, Guillón M, Mujica MC, Rojo LE, Fuentes P, Maccioni RB. Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. Journal of Alzheimer's Disease : Jad. 13: 225-32. PMID 18376063 DOI: 10.3233/Jad-2008-13211  0.553
2008 Rojo LE, Fernández JA, Maccioni AA, Jimenez JM, Maccioni RB. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Archives of Medical Research. 39: 1-16. PMID 18067990 DOI: 10.1016/j.arcmed.2007.10.001  0.674
2006 Rojo L, Sjöberg MK, Hernández P, Zambrano C, Maccioni RB. Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. Journal of Biomedicine & Biotechnology. 2006: 73976. PMID 17047312 DOI: 10.1155/Jbb/2006/73976  0.671
Show low-probability matches.